UH scientist explores bioprinting to save soldiers
A retired Army colonel at JABSOM is pioneering bioprinting research to develop life-saving treatments for soldiers and civilians alike.
A retired Army colonel at JABSOM is pioneering bioprinting research to develop life-saving treatments for soldiers and civilians alike.
Researchers developed a novel nanoparticle system to deliver drugs directly to lung cells, potentially easing COVID-19-related lung injury.
The terminated programs raise concerns about long-term impacts on Hawaiʻi’s biomedical workforce.
JABSOM’s Diabetes Research Center will use the grant renewal to continue critical research.
UH brought in $58 million in federal biomedical research grants to the state in fiscal year 2023.
UH’s microbiome center has developed an insectary, microscopy and genomic analysis cores that benefit research across disciplines.
The UH medical school’s Institutional Development Award Networks of Biomedical Research Excellence received funding from the National Institutes of Health.
Cumulina, the first cloned mouse and the first cloned mammal in the United States recently made the trek to her new home in the renowned Smithsonian’s National Museum of American History.
UH Mānoa accounted for $49,613,708 million in research funding awarded by the National Institutes of Health in fiscal year 2021.
The study is based on the prediction that additional variants will be found in Hawaiʻi because of its high influx of recreational travelers from COVID-19 hotspots.